{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:28:11Z","timestamp":1787585291572,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T00:00:00Z","timestamp":1704758400000},"content-version":"vor","delay-in-days":1103,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Bausch Health US, LLC","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11605-020-04671-x","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T14:05:16Z","timestamp":1597068316000},"page":"293-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Peripherally Acting \u03bc-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review"],"prefix":"10.1016","volume":"25","author":[{"given":"Karim","family":"Chamie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishnukamal","family":"Golla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T.","family":"Lenis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Lec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene R.","family":"Viscusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-020-04671-x_bb0010","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jviscsurg.2016.08.010","article-title":"Postoperative ileus: pathophysiology, incidence, and prevention","volume":"153","author":"Venara","year":"2016","journal-title":"J Visc Surg."},{"key":"10.1007\/s11605-020-04671-x_bb0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1345\/aph.1Q041","article-title":"Influence of intravenous opioid dose on postoperative ileus","volume":"45","author":"Barletta","year":"2011","journal-title":"Ann Pharmacother."},{"key":"10.1007\/s11605-020-04671-x_bb0020","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.clnu.2015.01.016","article-title":"Postoperative ileus: recent developments in pathophysiology and management","volume":"34","author":"Bragg","year":"2015","journal-title":"Clin Nutr."},{"key":"10.1007\/s11605-020-04671-x_bb0025","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1517\/13543784.17.9.1365","article-title":"Methylnaltrexone, a new peripherally acting mu-opioid receptor antagonist being evaluated for the treatment of postoperative ileus","volume":"17","author":"Kraft","year":"2008","journal-title":"Expert Opin Investig Drugs."},{"key":"10.1007\/s11605-020-04671-x_bb0030","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1185\/03007995.2015.1005833","article-title":"Impact of postsurgical opioid use and ileus on economic outcomes in gastrointestinal surgeries","volume":"31","author":"Gan","year":"2015","journal-title":"Curr Med Res Opin."},{"key":"10.1007\/s11605-020-04671-x_bb0035","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/SLA.0b013e31816d950e","article-title":"Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database","volume":"247","author":"Delaney","year":"2008","journal-title":"Ann Surg."},{"key":"10.1007\/s11605-020-04671-x_bb0040","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00464-009-0652-7","article-title":"Gastrointestinal recovery after laparoscopic colectomy: results of a prospective, observational, multicenter study","volume":"24","author":"Delaney","year":"2010","journal-title":"Surg Endosc."},{"key":"10.1007\/s11605-020-04671-x_bb0045","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/gut.2007.120238","article-title":"Intestinal handling-induced mast cell activation and inflammation in human postoperative ileus","volume":"57","author":"The FO","year":"2008","journal-title":"Gut."},{"issue":"suppl 13","key":"10.1007\/s11605-020-04671-x_bb0050","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.2146\/ajhp070428","article-title":"Pathogenesis and clinical and economic consequences of postoperative ileus","volume":"64","author":"Senagore","year":"2007","journal-title":"Am J Health Syst Pharm."},{"key":"10.1007\/s11605-020-04671-x_bb0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jss.2015.10.047","article-title":"Independent risk factors for prolonged postoperative ileus development","volume":"201","author":"Murphy","year":"2016","journal-title":"J Surg Res."},{"key":"10.1007\/s11605-020-04671-x_bb0060","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3748\/wjg.v16.i17.2067","article-title":"Postoperative ileus: impact of pharmacological treatment, laparoscopic surgery and enhanced recovery pathways","volume":"16","author":"Augestad","year":"2010","journal-title":"World J Gastroenterol."},{"key":"10.1007\/s11605-020-04671-x_bb0065","article-title":"Epidural local anaesthetics versus opioid-based analgesic regimens for postoperative gastrointestinal paralysis, vomiting and pain after abdominal surgery","volume":"7","author":"Guay","year":"2016","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1007\/s11605-020-04671-x_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/SLA.0b013e31805dac11","article-title":"Systemic lidocaine shortens length of hospital stay after colorectal surgery: a double-blinded, randomized, placebo-controlled trial","volume":"246","author":"Herroeder","year":"2007","journal-title":"Ann Surg."},{"key":"10.1007\/s11605-020-04671-x_bb0075","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/AJP.0b013e31819a506b","article-title":"Opioid-sparing effects of ketorolac and its correlation with the recovery of postoperative bowel function in colorectal surgery patients: a prospective randomized double-blinded study","volume":"25","author":"Chen","year":"2009","journal-title":"Clin J Pain."},{"key":"10.1007\/s11605-020-04671-x_bb0080","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4251\/wjgo.v8.i7.543","article-title":"Opioid-sparing effect of selective cyclooxygenase-2 inhibitors on surgical outcomes after open colorectal surgery within an enhanced recovery after surgery protocol","volume":"8","author":"Lohsiriwat","year":"2016","journal-title":"World J Gastrointest Oncol."},{"key":"10.1007\/s11605-020-04671-x_bb0085","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cgh.2017.05.014","article-title":"Opioids in gastroenterology: Treating adverse effects and creating therapeutic benefits","volume":"15","author":"Camilleri","year":"2017","journal-title":"Clin Gastroenterol Hepatol."},{"key":"10.1007\/s11605-020-04671-x_bb0090","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1213\/ane.0b013e31819e0d3a","article-title":"Peripherally acting mu-opioid receptor antagonists and postoperative ileus: mechanisms of action and clinical applicability","volume":"108","author":"Viscusi","year":"2009","journal-title":"Anesth Analg."},{"key":"10.1007\/s11605-020-04671-x_bb0095","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.2147\/DDDT.S32684","article-title":"Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction","volume":"9","author":"Leppert","year":"2015","journal-title":"Drug Des Devel Ther."},{"key":"10.1007\/s11605-020-04671-x_bb0100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/AAP.0000000000000671","article-title":"The efficacy of peripheral opioid antagonists in opioid-induced constipation and postoperative ileus: a systematic review of the literature","volume":"42","author":"Schwenk","year":"2017","journal-title":"Reg Anesth Pain Med."},{"key":"10.1007\/s11605-020-04671-x_bb0105","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0885-3924(01)00369-4","article-title":"Low-dose oral naloxone reverses opioid-induced constipation and analgesia","volume":"23","author":"Liu","year":"2002","journal-title":"J Pain Symptom Manage."},{"key":"10.1007\/s11605-020-04671-x_bb0110","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00115550-200011000-00016","article-title":"Antagonism of gastrointestinal opioid effects","volume":"25","author":"Yuan","year":"2000","journal-title":"Reg Anesth Pain Med."},{"key":"10.1007\/s11605-020-04671-x_bb0115","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejphar.2018.08.004","article-title":"On the front lines of the opioid epidemic: rescue by naloxone","volume":"835","author":"Skolnick","year":"2018","journal-title":"Eur J Pharmacol."},{"key":"10.1007\/s11605-020-04671-x_bb0120","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S0140-6736(09)60139-2","article-title":"Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus","volume":"373","author":"Becker","year":"2009","journal-title":"Lancet."},{"issue":"suppl 1","key":"10.1007\/s11605-020-04671-x_bb0125","first-page":"119","article-title":"New approaches to the treatment of opioid-induced constipation","volume":"12","author":"Holzer","year":"2008","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1007\/s11605-020-04671-x_bb0130","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/1756283X16648869","article-title":"The role of naloxegol in the management of opioid-induced bowel dysfunction","volume":"9","author":"Leppert","year":"2016","journal-title":"Therap Adv Gastroenterol."},{"key":"10.1007\/s11605-020-04671-x_bb0135","first-page":"129","article-title":"A retrospective study of patients undergoing radical cystectomy and receiving peri-operative naloxegol or alvimopan: comparison of length of stay","volume":"6","author":"Goodstein","year":"2018","journal-title":"J Surg (N Y N Y)."},{"key":"10.1007\/s11605-020-04671-x_bb0140","unstructured":"Entereg [package insert]. Whitehouse Station, NJ: Merck Sharp & Dohme Corp; 2015."},{"key":"10.1007\/s11605-020-04671-x_bb0145","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archsurg.143.11.1098","article-title":"Gastrointestinal tract recovery in patients undergoing bowel resection: results of a randomized trial of alvimopan and placebo with a standardized accelerated postoperative care pathway","volume":"143","author":"Ludwig","year":"2008","journal-title":"Arch Surg."},{"key":"10.1007\/s11605-020-04671-x_bb0150","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2036.2008.03696.x","article-title":"Clinical trial: alvimopan for the management of post-operative ileus after abdominal surgery: results of an international randomized, double-blind, multicentre, placebo-controlled clinical study","volume":"28","author":"Buchler","year":"2008","journal-title":"Aliment Pharmacol Ther."},{"key":"10.1007\/s11605-020-04671-x_bb0155","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s00464-005-0104-y","article-title":"Alvimopan, a peripherally acting mu-opioid receptor antagonist, compared with placebo in postoperative ileus after major abdominal surgery: results of a randomized, double-blind, controlled study","volume":"20","author":"Viscusi","year":"2006","journal-title":"Surg Endosc."},{"key":"10.1007\/s11605-020-04671-x_bb0160","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s10350-005-0035-7","article-title":"Phase III trial of alvimopan, a novel, peripherally acting, mu opioid antagonist, for postoperative ileus after major abdominal surgery","volume":"48","author":"Delaney","year":"2005","journal-title":"Dis Colon Rectum."},{"key":"10.1007\/s11605-020-04671-x_bb0165","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/01.sla.0000141158.27977.66","article-title":"Alvimopan, a novel, peripherally acting mu opioid antagonist: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial of major abdominal surgery and postoperative ileus","volume":"240","author":"Wolff","year":"2004","journal-title":"Ann Surg."},{"key":"10.1007\/s11605-020-04671-x_bb0170","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajog.2006.01.039","article-title":"A double-blind, randomized, placebo-controlled phase III study of the safety of alvimopan in patients who undergo simple total abdominal hysterectomy","volume":"195","author":"Herzog","year":"2006","journal-title":"Am J Obstet Gynecol."},{"key":"10.1007\/s11605-020-04671-x_bb0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.eururo.2014.02.036","article-title":"Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial","volume":"66","author":"Lee","year":"2014","journal-title":"Eur Urol."},{"key":"10.1007\/s11605-020-04671-x_bb0180","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.amjsurg.2005.10.026","article-title":"Postoperative upper and lower gastrointestinal recovery and gastrointestinal morbidity in patients undergoing bowel resection: pooled analysis of placebo data from 3 randomized controlled trials","volume":"191","author":"Delaney","year":"2006","journal-title":"Am J Surg."},{"key":"10.1007\/s11605-020-04671-x_bb0185","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1097\/DCR.0000000000001181","article-title":"Evaluation of healthcare use and clinical outcomes of alvimopan in patients undergoing bowel resection: a propensity score-matched analysis","volume":"61","author":"Steele","year":"2018","journal-title":"Dis Colon Rectum."},{"key":"10.1007\/s11605-020-04671-x_bb0190","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s11605-018-3846-2","article-title":"Alvimopan, regardless of ileus risk, significantly impacts ileus, length of stay, and readmission after intestinal surgery","volume":"22","author":"Al-Mazrou","year":"2018","journal-title":"J Gastrointest Surg."},{"key":"10.1007\/s11605-020-04671-x_bb0195","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/jim-2017-000449","article-title":"Cost and efficacy examination of alvimopan for the prevention of postoperative ileus","volume":"65","author":"Nemeth","year":"2017","journal-title":"J Investig Med."},{"key":"10.1007\/s11605-020-04671-x_bb0200","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/ajgsup.2014.8","article-title":"An evidence-based review of novel and emerging therapies for constipation in patients taking opioid analgesics","volume":"2","author":"Brenner","year":"2014","journal-title":"Am J Gastroenterol Suppl."},{"key":"10.1007\/s11605-020-04671-x_bb0205","unstructured":"Relistor [package insert]. Bridgewater, NJ: Salix Pharmaceuticals; 2018."},{"key":"10.1007\/s11605-020-04671-x_bb0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jhm.943","article-title":"Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery","volume":"7","author":"Anissian","year":"2012","journal-title":"J Hosp Med."},{"key":"10.1007\/s11605-020-04671-x_bb0215","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/21556660.2013.838169","article-title":"Randomized placebo-controlled study of intravenous methylnaltrexone in postoperative ileus","volume":"2","author":"Viscusi","year":"2013","journal-title":"J Drug Assess."},{"key":"10.1007\/s11605-020-04671-x_bb0220","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/DCR.0b013e3182092bde","article-title":"Safety and efficacy of methylnaltrexone in shortening the duration of postoperative ileus following segmental colectomy: results of two randomized, placebo-controlled phase 3 trials","volume":"54","author":"Yu","year":"2011","journal-title":"Dis Colon Rectum."},{"key":"10.1007\/s11605-020-04671-x_bb0225","doi-asserted-by":"crossref","unstructured":"Lenis AT, Golla V, Lec PM, et al. The association between N-methylnaltrexone, a peripherally acting mu-opioid receptor antagonist, and clinical outcomes in patients undergoing robotic-assisted radical cystectomy. World J Urol. 2020; https:\/\/doi.org\/10.1007\/s00345-020-03117-y","DOI":"10.1007\/s00345-020-03117-y"},{"key":"10.1007\/s11605-020-04671-x_bb0230","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.pain.2007.11.008","volume":"137","author":"Webster","year":"2008","journal-title":"Pain."},{"key":"10.1007\/s11605-020-04671-x_bb0235","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2217\/14622416.9.7.905","article-title":"Pharmacogenetics of analgesics: toward the individualization of prescription","volume":"9","author":"Rollason","year":"2008","journal-title":"Pharmacogenomics."},{"key":"10.1007\/s11605-020-04671-x_bb0240","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1093\/pm\/pnx148","article-title":"Long-term safety and efficacy of subcutaneous methylnaltrexone in patients with opioid-induced constipation and chronic noncancer pain: a phase 3, open-label trial","volume":"18","author":"Webster","year":"2017","journal-title":"Pain Med."},{"key":"10.1007\/s11605-020-04671-x_bb0245","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/annonc\/mdw317","article-title":"Treatment with methylnaltrexone is associated with increased survival in patients with advanced cancer","volume":"27","author":"Janku","year":"2016","journal-title":"Ann Oncol."},{"key":"10.1007\/s11605-020-04671-x_bb0250","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/hed.21759","article-title":"Modulation of the opioid growth factor ([Met(5)]-enkephalin)-opioid growth factor receptor axis: novel therapies for squamous cell carcinoma of the head and neck","volume":"34","author":"McLaughlin","year":"2012","journal-title":"Head Neck."},{"key":"10.1007\/s11605-020-04671-x_bb0255","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0625.2010.01158.x","article-title":"Endogenous mu-opioid peptides modulate immune response towards malignant melanoma","volume":"20","author":"Boehncke","year":"2011","journal-title":"Exp Dermatol."},{"issue":"suppl 1","key":"10.1007\/s11605-020-04671-x_bb0260","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/bja\/aeu090","article-title":"Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer","volume":"113","author":"Nguyen","year":"2014","journal-title":"Br J Anaesth."},{"key":"10.1007\/s11605-020-04671-x_bb0265","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1213\/ANE.0b013e31820568af","article-title":"The novel role of the mu opioid receptor in lung cancer progression: a laboratory investigation","volume":"112","author":"Mathew","year":"2011","journal-title":"Anesth Analg."},{"key":"10.1007\/s11605-020-04671-x_bb0270","unstructured":"Movantik [package insert]. Wilmington, DE: AstraZeneca Pharmaceuticals; 2018."},{"key":"10.1007\/s11605-020-04671-x_bb0275","unstructured":"Symproic [package insert]. Florham Park, NJ: Shionogi Inc.; 2018."}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-020-04671-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11605-020-04671-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23007588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23007588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-020-04671-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:01:15Z","timestamp":1761076875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23007588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1091255X23007588"],"URL":"https:\/\/doi.org\/10.1007\/s11605-020-04671-x","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripherally Acting \u03bc-Opioid Receptor Antagonists in the Management of Postoperative Ileus: a Clinical Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-020-04671-x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 The Author(s)","name":"copyright","label":"Copyright"}]}}